Tonix Pharmaceuticals Logo

  • About
    • Leadership
      • Executive Team
      • Board of Directors
    • Facilities
    • State Disclosures
  • Therapeutic Areas Overview
    • Central Nervous System
      • Fibromyalgia
      • Migraine
    • Immunology
      • Organ Transplant Rejection
      • Gastro-Intestinal Cancers
    • Infectious Disease
      • Mpox (Monkey Pox)
      • Smallpox
  • Pipeline
    • Central Nervous System
      • TNX-102 SL
    • Immunology
      • TNX-1500
      • TNX-1700
    • Infectious Disease
      • TNX-801
      • TNX-4200 CD45
    • Expanded Access Policy
  • Medicines
  • Clinical Trials
  • News & Events
    • Press Releases
    • Tonix in the News
    • Tonix Sponsored News
    • Investor Presentations
    • Scientific Presentations
    • IR Events
    • Op-eds
  • Investors
    • News & Events
    • Presentations
      • Investor Presentations
      • Scientific Presentations
      • Program Specific Presentations
      • Conference Materials
    • Multimedia
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact Us

Tonix in the News

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Tonix in the News
    • Tonix Sponsored News
    • IR Events
    • Email Alerts
    • Op-Eds
  • Presentations
  • Multimedia
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • Form 8937
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Tonix in the News
  • Tonix Sponsored News
  • IR Events
  • Email Alerts
  • Op-Eds
Technology Networks | Jun 1, 2021

Dr. Seth Lederman discusses T Cell Immunity and COVID-19 on Technology Networks

Bloomberg | May 25, 2021

Dr. Seth Lederman Discusses COVID-19 Vaccine durability and further development on Bloomberg Radio

Bloomberg | Mar 23, 2021

Dr. Seth Lederman interviewed on Nobel Laureate Economist on Vaccine Equity

ABC FOX Montana | Jan 6, 2021

Dr. Seth Lederman interviewed on ABC FOX Montana to discuss highlights of Tonix’s planned vaccine manufacturing facility in Hamilton, MT

Contagion Live | Dec 4, 2020

Dr. Seth Lederman interviewed on Contagion Live to discuss its COVID-19 vaccine in development

Bloomberg | Jun 9, 2020

Dr. Seth Lederman interviewed on Bloomberg Radio to discuss COVID-19 Vaccine development

Technology Networks | Apr 7, 2020

Dr. Seth Lederman’s interview with the Science Writer for Technology Networks

New England Journal of Medicine | Mar 30, 2020

Developing Covid-19 Vaccines at Pandemic Speed

Washington Examiner | Jan 1, 2019

Military-related PTSD: Our year to act

Washington Post | Jul 7, 2017

Scientists synthesize smallpox cousin in ominous breakthrough

Science | Jul 6, 2017

How Canadian researchers reconstituted an extinct poxvirus for $100,000 using mail-order DNA

The National Post | Mar 2, 2017

Canadian synthesizes a better smallpox vaccine - just in case terrorists bring the disease back

Reuters | May 19, 2016

Tonix Pharma PTSD drug shows promise in mid-stage study

Medscape | Nov 17, 2015

New Approach to Fibromyalgia Tackles Poor-Quality Sleep

PharmaVOICE | Nov 16, 2015

21st Century Cures Act

BioPharma Dive | Oct 8, 2015

An innovation challenge: Using pharma R&D as a tool for social change

Life Science Leader | Jul 1, 2015

Companies to Watch: Tonix Pharmaceuticals

Bioworld Today | May 14, 2015

Lead ‘tonic’ for Tonix targets fibromyalgia in phase III study

Fibromyalgia News Today | May 14, 2015

Tonix Pharmaceuticals Launches Phase 3 Clinical Trial To Evaluate Experimental Fibromyalgia Therapy

The Medicine Maker | May 5, 2015

The Big Leap from Academic to Entrepreneur

rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Pagearrow_forward
email icon Sign up for Email Alerts
twitter icon linkedin icon facebook icon
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Site Map

© 2025 Tonix Pharmaceuticals Holding Corp.